News from NYU Langone Health
Celebrate cancer win and continue work
Newsday
An editorial celebrates a new personalized mRNA cancer vaccine for melanoma from Merck and Moderna, highlighting Long Island's contribution to the research. The piece notes that the Phase 3 clinical trial included two patients at NYU Langone Hospital-Long Island in Mineola. It also points to the proposed new NYU Langone complex in Melville as a significant future development for the region's expanding research and healthcare sectors. The article calls for public policy and funding to support these ongoing scientific advancements, mentioning competitors like Memorial Sloan Kettering.
8/26/2026
Why Melville could be Long Island’s next major development hub
Substack
NYU Langone Health is spearheading the transformation of Melville’s commercial landscape with a planned 45-acre academic medical center. Following a $135.5 million property acquisition, the health system intends to build Long Island’s first ground-up hospital in nearly 50 years. The facility will house over 500 private patient rooms, 70 emergency bays, a medical school, and research laboratories. The project is expected to generate 8,000 union construction jobs and thousands of permanent positions. Positioned within the "Melville Town Center," NYU Langone’s campus will serve as a vital catalyst for turning aging office parks into a walkable mixed-use district.
8/26/2026
Scientists studied 338 NFL players’ brains after death. Nearly all had the same disease
Gizmodo
A new study examining the brains of 338 deceased former NFL players found that 93% had chronic traumatic encephalopathy (CTE). Commenting on the research, Steven Galetta, MD, the Philip K. Moskowitz, MD Professor and chair of Neurology at NYU Langone Health, called the findings 'sobering.' However, he urged caution regarding potential selection bias, as players who are near death may be more inclined to donate their brains for study. He added that the pathological findings are important and require further investigation.
Also reporting was: Aol, The New York Times
8/25/2026
Study: 25% of NFL players who died between 2016 and 2021 had CTE
FOX 5 Health News
Devi Nampiaparampil, MD, a clinical associate professor at the Department of Rehabilitation Medicine at NYU Grossman School of Medicine, analyzes new data revealing that at least 25% of deceased NFL players had Chronic Traumatic Encephalopathy (CTE). She explains the actual prevalence is likely much higher, as nearly 100% of players who donated their brains for study showed signs of the disease. Dr. Nampiaparampil clarifies that CTE is caused by repeated head impacts and general brain stress, even without obvious concussion symptoms. While currently only diagnosable after death, she highlights that living individuals with brain-related symptoms can utilize cognitive and speech rehabilitation to improve their quality of life.
8/25/2026
Long-thought cause of autism not linked to symptoms, study finds
Daily Mail
A new study from researchers at NYU Langone Health found no significant link between prenatal exposure to organophosphate pesticides and autism-related symptoms in children. The research, published in JAMA Pediatrics, was led by Haleigh Cavalier, a former doctoral student at NYU Langone Health's Departments of Population Health and Pediatrics, and senior author Akhgar Ghassabian, MD, PhD, associate professor in the Department of Pediatrics at the NYU Grossman School of Medicine. The team analyzed data from over 3,300 mother-child pairs, finding no consistent association between pesticide metabolite levels in mothers during pregnancy and autism traits in their children.
Also reporting was: MSN, WDBJ-TV (Roanoke, VA)
8/25/2026
Beloved Kips Bay movie theater to shutter at the end of 2026
New York Post
The curtain is closing on the AMC Kips Bay IMAX theater after becoming a staple for movie goers for nearly three decades. An AMC employee has confirmed to the Post that no date has been set for the closure and that the location will operate until the end of the year. The property owner is reportedly ending the lease before its scheduled expiration and "details are still being finalized." A community group claims that NYU Langone Health will be taking the lot and is urging residents to sign a petition. NYU Langone has not commented on the property.
Also reporting was: Spectrum News NY1, Bradenton Herald, Yahoo.
8/25/2026
GLP-1s: Is there a ‘best’ GLP-1 injection site?
Medscape
While social media users debate the best injection site for GLP-1 medications, medical experts state there is no evidence that one approved site is better than another for absorption or effectiveness. The FDA recommends subcutaneous injections in the abdomen, thigh, or upper arm. Michael Weintraub, MD, an endocrinologist and obesity specialist and clinical assistant professor of medicine at NYU Langone Health, reassures patients that as long as the medication is injected into one of the recommended areas, it does not affect the drug's efficacy. Clinicians advise rotating injection sites to prevent scar tissue formation.
8/25/2026
Chemotherapy-free treatment shows promise for some metastatic breast cancer patients
HealthDay
A new chemo-free treatment regimen for HR-positive, HER2-positive metastatic breast cancer may allow some patients to avoid chemotherapy as an initial treatment, according to a small, early-stage trial. The study, which included authors from NYU Langone Health and Icahn School of Medicine at Mount Sinai, tested four targeted therapies in 29 patients. The regimen combines hormone therapy with medicines targeting tumor growth pathways. Results showed 97% of participants experienced clinical benefit during the first six months, and patients went a median of nearly 25 months before their cancer progressed. The findings require confirmation in larger trials.
8/25/2026
New York experts push for coordinated obesity care teams
American Journal of Managed Care
New York City experts gathered to discuss challenges in building coordinated obesity care teams. Among the panelists, Stanislaw Klek, MD, chief of Endocrinology, Diabetes and Metabolism, NYU Langone Hospital - Long Island, detailed his institution's 'Pathways for Obesity' hotline for patient routing. Manish Parikh, MD, a general and bariatric surgeon at NYU Langone General Surgery Associates and director of bariatric surgery at Bellevue Hospital Center, spoke on the fragmented state of care. The conversation also covered different care models at institutions like Montefiore and NYC Health + Hospitals, staff shortages, and how insurance policies often dictate treatment over clinical judgment.
8/25/2026
A growing trend among retirees is sparking neighborhood disputes
Cleveland.com
Cannabis use among older Americans is rising, leading to neighborhood disputes over odors and secondhand smoke. While many seniors turn to marijuana for medical reasons, conflicts are increasing. Joseph Palamar, MPH, PhD, professor in the Department of Population Health at NYU Grossman School of Medicine, stated that social influence is a contributing factor. The article also references research from NYU Langone Health showing that a small percentage of seniors use cannabis to feel included among peers. The piece notes the division among medical experts on the risks versus benefits for this demographic.
8/25/2026
8 health systems edging ahead in the ASC race
Becker's ASC Review
NYU Langone Health is highlighted as one of eight health systems leading the expansion into the Ambulatory Surgery Center (ASC) market in 2026. The system's recent developments include opening a 54,000-square-foot ambulatory center in Patchogue, a 12,000-square-foot care location in Brooklyn, and a 25,000-square-foot center in Riverhead. Additionally, NYU Langone Health announced plans for a new ASC in Manhasset. The report also notes competitor Northwell Health for its own ASC growth, including a new pediatric orthopedic and urology center in New Hyde Park.
8/25/2026
Reshaping advanced cutaneous squamous cell carcinoma management beyond surgery
Dermatology Times
An article details discussions from three recent events on managing advanced cutaneous squamous cell carcinoma (cSCC), one of which was moderated by Darrell Rigel, MD, clinical professor in the Ronald O. Perelman Department of Dermatology at NYU Grossman School of Medicine. The events brought together dermatologists, Mohs surgeons, and medical oncologists to examine how systemic immunotherapy options are changing collaboration and treatment decisions. Discussions focused on comparing trial data for three approved checkpoint inhibitors—cemiplimab, pembrolizumab, and cosibelimab—and bridging referral gaps between dermatology and oncology. Every dermatologist in Dr. Rigel's session indicated they would refer patients with advanced disease for systemic therapy.
8/25/2026
AI-detection tools have made huge leaps forward — how good are they?
Nature
AI-detection tools like Pangram and GPTZero have improved, claiming high accuracy in distinguishing AI-written from human-written text. These tools are being used by research organizations and universities to screen submissions. According to Tim Requarth, PhD, research assistant professor in the Department of Neuroscience at NYU Grossman School of Medicine, while the detectors are 'good for screening out places that are pumping out slop,' their results are less reliable for AI-edited writing. He notes that he does not have much faith in the exact percentages given by the tools for cases involving AI assistance rather than full AI generation.
8/24/2026
